July 26, SEOUL, South Korea. In our seminar series ‘Present and Future of Vaccine Development’, we were happy to welcome our latest speaker: Doctor of Veterinary Medicine (DVM), Jong-Hyeon Park, PhD., Head of the Center for FMD Vaccine Research Animal and Plant Quarantine Agency. He reviewed the current knowledge on foot-and-mouth disease (FMD) vaccines, supported by his local experience, and provided an outlook on novel technologies as potential alternatives to better control and eradicate the disease. The seminar was sponsored by the ChongKunDang Kochon Foundation.
Please find the abstract below.
Improved vaccine for foot-and-mouth-disease control
Of the foot-and-mouth disease virus (FMDV) serotypes, type O, A, and SAT2 most frequently cause FMD outbreaks across the world. FMD vaccines are used as the most powerful preventive and disease-controlling measure. In many cases, there is no cross-immunity among the same topotypes depending on the genetic lineage, so selecting the proper vaccine is very important for ensuring prevention and early protection. Most importantly, to effectively control an FMD outbreak, the immunogenicity and protection capacity of the vaccine used against the field viruses in the region should be rapidly determined. Accordingly, because of the emergence of newly evolved viruses, efforts to develop newly improved vaccines have become very important. Specifically, vaccines that are capable of providing broad and complete protection against such viruses are also required.